Adverse reactions induced by topical drugs;Reactions cutanees aux medicaments topiques

Revue du Praticien

Volumn 50, Issue 12, 2000, Pages 1324-1328

  Barbaud, Annick ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALCOHOL; ALUMINUM; ANTIINFECTIVE AGENT; BUFEXAMAC; CORTICOSTEROID; COSMETIC; ERYTHROMYCIN; ETHYLENEDIAMINE; EXCIPIENT; FLUOROURACIL; HEPARIN; HIRUDIN; IMIDAZOLE DERIVATIVE; KETOPROFEN; LOCAL ANESTHETIC AGENT; NEOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; POVIDONE IODINE; PROPYLENE GLYCOL; QUATERNARY AMMONIUM DERIVATIVE; SALICYLAMIDE; SALICYLIC ACID; SODIUM METABISULFITE; UNINDEXED DRUG; VIRGINIAMYCIN;

ARTICLE; CONTACT DERMATITIS; CONTACT SENSITIZATION; CORTICOSTEROID THERAPY; DRUG ADMINISTRATION ROUTE; DRUG CROSS REACTIVITY; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; HUMAN; PATCH TEST; SYSTEMIC DISEASE; CROSS REACTION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; PATHOPHYSIOLOGY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; COSMETICS; CROSS REACTIONS; DERMATITIS, CONTACT; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HUMANS; PATCH TESTS;

EID: 0034659533     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barbaud A, Tréchot P, Schmutz JL. Pharmacovigilance des accidents cutanés de contact aux médicaments.Ann Dermatol Venereol 1997; 124 : 474-5.
2. Barbaud A. Les allergies médicamenteuses de contact. Actualités et conseils vis-à-vis des prescriptions de médicaments administrés par voie générale. Rev Fr Allergol 1999; 39 : 301-10.
3. Barbaud A. Allergies cutanées aux préparations magistrales dermatologiques. In : Progrès en dermato-allergologie, Viternes : Mediscript, 1997 ; 3 : 97-106.
4. Baudot S, Milpied B, Larousse C. Kétoprofène et effets secondaires cutanés : bilan d'une enquête sur 337 notifications. Therapie 1998; 53 : 137-44.
5. Reichert-Penetrat S, Barbaud A, Weber M, Schmutz JL. Eczéma de contact et ulcères de jambe : à propos de 359 bilans. Ann Dermatol Venereol 1999; 126 : 131-5.
6. De Groot A, Weijland W. Conversion of common names of cosmetic allergens to the INCI nomenclature. Contact Dermatitis 1997; 37 : 145-50.
7. Barbaud A. Place of excipients in drug-related allergy. Clin Rev All Immunol 1995; 13 : 253-63.
8. Menné T, Veien N, Sjolin K-E, Maibach H. Systemic contact dermatitis.Am J Contact Dermatitis 1994; 5 : 1-12.
9. Ring J. Exacerbation of eczema by formalin, containing hepatitis B vaccine in formaldehyde-allergic patient. Lancet 1986; 2 : 522-3.
10. Dooms-Goossens A, Matura M, Drieghe J et al. Contact allergy to imidazoles used as antimytotic agents. Contact Dermatitis 1995; 33 : 73-7.
11. Fernandez L, Maquiera E, Rodriguez F et al. Systemic contact dermatitis from miconazole. Contact Dermatitis 1996; 34 : 217.
12. Van Dijke C, Veerman FR, Haverkamp HCh. Anaphylactic reactions to ketoconazole. BMJ 1983 ; 287 : 1673.
13. Ophaswongse S, Maibach H. Topical nonsteroidal anti-inflammatory drugs: allergic and photoallergic contact dermatitis and phototoxicity. Contact Dermatitis 1993 ; 29 : 57-64.
14. Barbaud A, Trechot P, Aublet-Cuvelier A, Reichert-Penetrat S, Schmutz JL. Bufexamac and diclofenac:frequency of contact sensitization and absence of cross-reactions. Contact Dermatitis 1998 ; 39 : 272-3.
15. Le Coz CJ, Bottlaender A, Scrivener JN et al. Photocontact dermatitis from ketoprofen and tiaprofenic acid: cross-reactivity study in 12 consecutive patients. Contact Dermatitis 1998 ; 38 : 245-52.
16. Stingeni L, Lopomarda V, Lisi P. What risk of piroxicam photodermatitis in thimerosal-positive patients? Contact Dermatitis 1996 ; 34 : 60-1.
17. Gonçalo M, Figueiro A, Gonçalo S. Hypersensitivity to thimerosal: the sensitizing moiety. Contact Dermatitis 1996 ; 34 : 201-3.
18. Rudzki E, Koslowska A. Sensitivity to salicylic acid. Contact Dermatitis 1976 ; 2 : 178.
19. Rudzki E, Rebandel P. Cross-reactions with 4 aminoglycoside antibiotics at various concentrations. Contact Dermatitis 1996 ; 35 : 62.
20. Barbaud A, Reichert-Penetrat S, Trechot P et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998 ; 139 : 49-58.
21. Mayence C, Dompmartin A, Verneuil L, Michel M, Leroy D. Value of patch tests in pristinamycin-induced drug eruptions. Contact Dermatitis 1999 ; 40 : 161-2.
22. Tabar Al, Garcia BE, Rodriguez A, Quirce S, Olaguibel JM. Etiologic agents in allergic contact dermatitis caused by eyedrops. Contact Dermatitis 1993 ; 28 : 50-1.
23. Carriere M, Giordano-Labadie F, Schwarze HP, Loche F, Bazex J. Difficulties in the interpretation of patch test reactions to ophtalmic β-blockers. Contact Dermatitis 1998 ; 39 : 319-20.
24. Dooms-Goossens A, Andersen KE, Brandao FM et al. Corticosteroid allergy : an EECDRG multicentre study. Contact Dermatitis 1996 ; 35 :40-4.
25. Lepoittevin JP, Drieghe J, Dooms-Goossens A. Studies in patients with corticosteroid contact allergy: understanding cross-reactivity among different steroids. Arch Dermatol 1995 ; 131 :31-7.
26. Stingeni L, Caraffini S, Assalve D et al. Erythema-multiforme-like contact dermatitis from budesonide. Contact Dermatitis 1996 ; 34 : 154-5.
27. Whitmore E. Delayed systemic allergic reactions to corticosteroids. Contact Dermatitis 1995 ; 32 : 193-8.